Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan J Suñer

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)|September 24, 2021
Dexamethasone Sustained-Release Intracanalicular Insert for Control of Postoperative Inflammation After Pars Plana VitrectomyIvan J Suñer, Marc C Peden
Retina (Philadelphia, Pa.)|March 26, 2019
ReplyMarc C Peden, Mark E Hammer, Ivan J Suñer
Retina (Philadelphia, Pa.)|August 25, 2018
DILUTE POVIDONE-IODINE PROPHYLAXIS MAINTAINS SAFETY WHILE IMPROVING PATIENT COMFORT AFTER INTRAVITREAL INJECTIONSMarc C Peden, Mark E Hammer, Ivan J Suñer
Retina (Philadelphia, Pa.)|July 22, 2014
Direct medical costs and resource use for treating central and branch retinal vein occlusion in commercially insured working-age and Medicare populationsIvan J Suñer, Jay Margolis, Kimberly Ruiz, et al.
Ophthalmology|January 19, 2015
Long-term outcomes in eyes receiving fixed-interval dosing of anti-vascular endothelial growth factor agents for wet age-related macular degenerationMarc C Peden, Ivan J Suñer, Mark E Hammer, et al.
Retina (Philadelphia, Pa.)|September 27, 2016
RESPONSIVENESS OF THE NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE-25 TO VISUAL ACUITY GAINS IN PATIENTS WITH DIABETIC MACULAR EDEMA: Evidence From the RIDE and RISE TrialsIvan J Suñer, Neil M Bressler, Rohit Varma, et al.
Investigative Ophthalmology & Visual Science|March 4, 2009
Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trialsIvan J Suñer, Gregg T Kokame, Elaine Yu, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|March 21, 2023
The 0.19-mg Fluocinolone Acetonide Implant for the Treatment of Diabetic Macular Edema: An Expert ConsensusAnton M Kolomeyer, David A Eichenbaum, Daniel F Kiernan, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|November 28, 2014
RaScaL: A Pilot Study to Assess the Efficacy, Durability, and Safety of a Single Intervention with Ranibizumab plus Peripheral Laser for Diabetic Macular Edema Associated with Peripheral Nonperfusion on Ultrawide-Field Fluorescein AngiographyIvan J Suñer, Marc C Peden, Mark E Hammer, et al.
American Journal of Ophthalmology Case Reports|December 9, 2020
Brolucizumab-related retinal vasculitis with exacerbation following ranibizumab retreatment: A clinicopathologic case studyPrashanth G Iyer, Marc C Peden, Ivan J Suñer, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Clinical Ophthalmology (Auckland, N.Z.)|September 24, 2021
Dexamethasone Sustained-Release Intracanalicular Insert for Control of Postoperative Inflammation After Pars Plana VitrectomyIvan J Suñer, Marc C Peden
Retina (Philadelphia, Pa.)|March 26, 2019
ReplyMarc C Peden, Mark E Hammer, Ivan J Suñer
Retina (Philadelphia, Pa.)|August 25, 2018
DILUTE POVIDONE-IODINE PROPHYLAXIS MAINTAINS SAFETY WHILE IMPROVING PATIENT COMFORT AFTER INTRAVITREAL INJECTIONSMarc C Peden, Mark E Hammer, Ivan J Suñer
Retina (Philadelphia, Pa.)|July 22, 2014
Direct medical costs and resource use for treating central and branch retinal vein occlusion in commercially insured working-age and Medicare populationsIvan J Suñer, Jay Margolis, Kimberly Ruiz, et al.
Ophthalmology|January 19, 2015
Long-term outcomes in eyes receiving fixed-interval dosing of anti-vascular endothelial growth factor agents for wet age-related macular degenerationMarc C Peden, Ivan J Suñer, Mark E Hammer, et al.
Retina (Philadelphia, Pa.)|September 27, 2016
RESPONSIVENESS OF THE NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE-25 TO VISUAL ACUITY GAINS IN PATIENTS WITH DIABETIC MACULAR EDEMA: Evidence From the RIDE and RISE TrialsIvan J Suñer, Neil M Bressler, Rohit Varma, et al.
Investigative Ophthalmology & Visual Science|March 4, 2009
Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trialsIvan J Suñer, Gregg T Kokame, Elaine Yu, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|March 21, 2023
The 0.19-mg Fluocinolone Acetonide Implant for the Treatment of Diabetic Macular Edema: An Expert ConsensusAnton M Kolomeyer, David A Eichenbaum, Daniel F Kiernan, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|November 28, 2014
RaScaL: A Pilot Study to Assess the Efficacy, Durability, and Safety of a Single Intervention with Ranibizumab plus Peripheral Laser for Diabetic Macular Edema Associated with Peripheral Nonperfusion on Ultrawide-Field Fluorescein AngiographyIvan J Suñer, Marc C Peden, Mark E Hammer, et al.
American Journal of Ophthalmology Case Reports|December 9, 2020
Brolucizumab-related retinal vasculitis with exacerbation following ranibizumab retreatment: A clinicopathologic case studyPrashanth G Iyer, Marc C Peden, Ivan J Suñer, et al.
Pageof 3